Home » Topics » Regulatory

Regulatory
RSS

FDA approves new labeling for Hyalgan

Jan. 28, 2000

New growth hormone option increases patient convenience

Jan. 25, 2000

Genotropin delivery device now available for long-term replacement therapy in GHD

Jan. 24, 2000

FDA approves two-dose regimen of Merck & Co.'s Recombivax HB for adolescent use

Jan. 21, 2000

KeraVision commences clinical trials for use of Intacs as treatment of keratoconus

Jan. 19, 2000

Clomethiazole: use in spinal cord injury

Jan. 18, 2000

European Commission approves new indication for AstraZeneca antiasthmatic

Jan. 17, 2000

FDA accepts NDA for new Rapamune formulation

Jan. 14, 2000

Once-daily antidiabetic drug from Andrx steadily advances towards market launch

Jan. 11, 2000

New combination therapy for depression with reduced side effects

Jan. 11, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...